Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
BMC Infect Dis ; 21(1): 502, 2021 May 29.
Artigo em Inglês | MEDLINE | ID: mdl-34051752

RESUMO

BACKGROUND: Heterozygous mutations in the transcription factor GATA2 result in a wide spectrum of clinical phenotypes, including monocytopenia and Mycobacterium avium complex (MAC) infection (MonoMAC) syndrome. Patients with MonoMAC syndrome typically are infected by disseminated nontuberculous mycobacteria, fungi, and human papillomavirus, exhibit pulmonary alveolar proteinosis during late adolescence or early adulthood, and manifest with decreased content of dendritic cells (DCs), monocytes, and B and natural killer (NK) cells. CASE PRESENTATION: A 39-year-old woman was diagnosed with MonoMAC syndrome postmortem. Although she was followed up based on the symptoms associated with leukocytopenia that was disguised as sarcoidosis with bone marrow involvement, she developed disseminated nontuberculous mycobacterial infection, fungemia, and MonoMAC syndrome after childbirth. Genetic testing revealed a heterozygous missense mutation in GATA2 (c.1114G > A, p.A372T). Immunohistochemistry and flow cytometry showed the disappearance of DCs and decreased frequency of NK cells in the bone marrow, respectively, after childbirth. CONCLUSIONS: To the best of our knowledge, this is the first study reporting that MonoMAC syndrome can be exacerbated after childbirth, and that immunohistochemistry of bone marrow sections to detect decreased DC content is useful to suspect MonoMAC syndrome.


Assuntos
Fungemia/diagnóstico , Deficiência de GATA2/genética , Fator de Transcrição GATA2/genética , Leucopenia/diagnóstico , Infecções por Mycobacterium não Tuberculosas/diagnóstico , Adulto , Antibacterianos/uso terapêutico , Evolução Fatal , Feminino , Fungemia/complicações , Fungemia/tratamento farmacológico , Deficiência de GATA2/complicações , Predisposição Genética para Doença , Humanos , Leucopenia/complicações , Leucopenia/tratamento farmacológico , Linfonodos/patologia , Mutação , Infecções por Mycobacterium não Tuberculosas/complicações , Infecções por Mycobacterium não Tuberculosas/tratamento farmacológico , Período Pós-Parto , Prednisona/uso terapêutico , Gravidez
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA